3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Cerebral Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, K; Miyake, H; Murakami, Y; Nanri, M; Watanabe, H | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Cerebral Infarction
| Article | Year |
|---|---|
GTS-21, a nicotinic agonist, attenuates multiple infarctions and cognitive deficit caused by permanent occlusion of bilateral common carotid arteries in rats.
Topics: Animals; Benzylidene Compounds; Brain; Carotid Artery, Common; Carotid Stenosis; Cerebral Cortex; Cerebral Infarction; Cognition Disorders; Corpus Striatum; Hippocampus; Male; Maze Learning; Nicotinic Agonists; Pyridines; Rats; Rats, Wistar | 1998 |